The two heads of the American Hospital Association and America’s Health Insurance Plans joined together to make a plea for cooperation in the name of cost control among doctors, nurses, hospitals, health plans and others, in an op-ed published by The Hill.
Rick Pollack and Marilyn Tavenner, president and CEO of the AHA and AHIP, respectively, outlined the successes being achieved in cost control in such areas as Medicare Advantage, Medicare Part D, Medicare Shared Savings Program and in Medicaid managed care plans.
But more work is needed in some areas, such as offering an adequate number of federal insurance exchange options and in the cost of life-saving drugs. “A healthy private market – with real choice, informed consumers, and effective care and treatments – can deliver better quality and affordable coverage for everyone,” they wrote.
In addition, they pointed to the surge in drug prices as fueling cost increases. "Unjustified and unaccountable spikes in prescription drug prices are the engine of higher costs," the two wrote. "Despite historic lows in overall cost growth for years, drug spending grew by more than 12 percent in 2014 – and is expected to outpace overall growth for the foreseeable future."